Scarica l'app Stockscreener
92.88
1.80%
1.64
Dopo l'orario di chiusura:
92.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$91.24
Aprire:
$91.205
Volume 24 ore:
6.45M
Relative Volume:
0.85
Capitalizzazione di mercato:
$119.00B
Reddito:
$33.54B
Utile/perdita netta:
$4.66B
Rapporto P/E:
25.66
EPS:
3.62
Flusso di cassa netto:
$5.19B
1 W Prestazione:
+3.96%
1M Prestazione:
+4.85%
6M Prestazione:
+3.19%
1 anno Prestazione:
+12.98%
Intervallo 1D:
$91.20
$92.96
Intervallo di 1 settimana:
$88.25
$92.96
Portata 52W:
$79.29
$96.25
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility - GlobeNewswire Inc.
Medtronic (MDT) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Medtronic to Report Q1 FY2026 Results Eyes Momentum in Global Markets - MSN
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Are Wall Street Analysts Bullish on Medtronic Stock? - Yahoo Finance
Those who invested in Medtronic (NYSE:MDT) a year ago are up 15% - simplywall.st
Medtronic, FMMC join forces to enhance surgical training in laparoscopic, hernia procedures - Daijiworld
Medtronic to Report Q1 FY2026 Results, Eyes Momentum in Global MarketsVietnam Investment Review - Vietnam Investment Review - VIR
Medtronic to announce financial results for its first quarter of fiscal year 2026 - Laotian Times
Medtronic Announces Q1 FY 2026 Earnings on August 19, 2025 - AInvest
Why Medtronic (MDT) is Poised to Beat Earnings Estimates Again - Yahoo Finance
United States Smart Pills Market Research and Company Analysis Report 2025-2033 Featuring Check-Cap, General Electric, Fujifilm, Koninklijke Philips, Medtronic, Olympus, Novartis, Otsuka - Yahoo Finance
Bernstein Adjusts Price Target on Medtronic to $97 From $93, Maintains Outperform Rating - MarketScreener
Medtronic (MDT) Invests in Orchestra BioMed's Strategic Expansion - GuruFocus
Medtronic: Diabetes Business Spin-Off Key To Overcoming Stagnation (NYSE:MDT) - Seeking Alpha
Medtronic gets EU nod for MiniMed 780G System - MSN
What are analysts’ price targets for Medtronic plc in the next 12 monthsMaximize gains with data-driven trading alerts - Jammu Links News
Medtronic plc Stock Analysis and ForecastInvest like a pro with expert recommendations - Jammu Links News
When is Medtronic plc stock expected to show significant growthAchieve rapid financial growth with smart picks - Jammu Links News
How does Medtronic plc generate profit in a changing economyInvest confidently with expert support - Jammu Links News
What markets is GDRX expanding into Is Medtronic plc stock a good long term investment optionUnlock powerful trading tools for investors - Jammu Links News
What are the technical indicators suggesting about Medtronic plcBuild a diversified portfolio for steady growth - jammulinksnews.com
How many analysts rate Medtronic plc as a “Buy”Get professional guidance for market timing - Jammu Links News
What is Medtronic plc company’s growth strategyNavigate market shifts with confidence - Jammu Links News
What institutional investors are buying Medtronic plc stockFree Stock Market Beginners Guide - jammulinksnews.com
What drives Medtronic plc stock priceInvest confidently with real-time updates - Jammu Links News
Should I hold or sell Medtronic plc stock in 2025Maximize your returns with smart trade entries - Jammu Links News
Medtronic plc stock outlook for YEARFast Exit and Entry Strategy Guide Offered - metal.it
What are Medtronic plc company’s key revenue driversAmplify your gains with low-risk picks - jammulinksnews.com
Medtronic’s Long-term Cardiac Device Study: Implications for Investors - The Globe and Mail
Is Medtronic plc stock overvalued or undervaluedDaily Trading Alerts For Every Investor - jammulinksnews.com
Medtronic (MDT) Stock Moves -1.05%: What You Should Know - Yahoo Finance
Breakout Traders Target Medtronic plc on Recovery SetupFast Entry High Potential Stock Alerts Triggered - metal.it
Orchestra BioMed secures $70 million from Ligand and Medtronic By Investing.com - Investing.com UK
Ligand and Medtronic invest $70mln in Orchestra BioMed for AVIM therapy. - AInvest
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewswire
Medtronic PLC (MDT) Shareholder Update: Hedge Funds Increase Holdings by 0.18% - AInvest
Medtronic: Growth Challenges Persist (NYSE:MDT) - Seeking Alpha
Drawdown in Medtronic plc May Be Nearing EndWeekly Setup With 3x Return Potential Published - beatles.ru
Why Is Medtronic Exiting Diabetes? - Medical Device and Diagnostic industry
Will Medtronic Bring the Renal Denervation Market to the Forefront? - Medical Device and Diagnostic industry
What the charts say about Medtronic plc todayDaily Smart Money Movement Monitor Activated - metal.it
Bollinger Bands Show Potential Breakout in Medtronic plcLow Risk Equity Screener With Results Shared - metal.it
Mizuho Lifts PT on Medtronic (MDT) to $100 From $98, Keeps an Outperform Rating - MSN
Why Medtronic (MDT) is One of the Most Trusted Safe Dividend Stocks in Healthcare - MSN
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know - Nasdaq
Why is Medtronic plc stock attracting strong analyst attentionRetirement Planning Review With Proven Results - jammulinksnews.com
Medtronic shares snapped six-session winning streak (NYSE:MDT) - Seeking Alpha
Is it the right time to buy Medtronic plc stockUnlock powerful investment tools for free - jammulinksnews.com
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):